Continuous administration trial of PEGASUS-PC Study (Phase2/3 study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer)
Not Applicable
- Conditions
- nresectable Advanced and Recurrent Pancreatic Cancer
- Registration Number
- JPRN-UMIN000005133
- Lead Sponsor
- OncoTherapy Science, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing particular
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method